table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
anticoagulant
anticoagulant, curative dose REMAP-CAP, ACTIV-4a, ATTACC ... COVID-PACT
anticoagulation, intermediate prophylactic dose INSPIRATION
heparin at therapeutic dose ACTIV-4a ... REMAP-CAP Anticoagulation ATTACC ...

1 studies excluded by filtering options 1

5071 Tang, 2020 1133not a RCThigh risk of bias

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons